
NASDAQIndustrialsIntegrated Freight & Logistics
最新資料
US$16.84
−US$0.51 · -2.94%
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
收盤時
US$16.84
−US$0.51 · -2.94%
盤後
US$16.84
US$0.00 · 0.00%
10月12日 下午4:39 ET
盤中時間採用ET。市場資料可能有所延遲。
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
日內區間
目前US$16.84
52週區間
目前US$16.84
盤中時間採用ET。市場資料可能有所延遲。
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
日內區間
目前US$16.84
52週區間
目前US$16.84
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 1.76億 USD | 2.33億 USD | 2.37億 USD | 2.23億 USD | 2.23億 USD |
| 銷貨成本 | 9312.3萬 USD | 1.34億 USD | 1.33億 USD | 1.26億 USD | 1.26億 USD |
| 毛利 | 8305.4萬 USD | 9933.2萬 USD | 1.04億 USD | 9657.7萬 USD | 9657.7萬 USD |
| 研究與開發 | 1704.1萬 USD | 1804萬 USD | 1572.2萬 USD | 1684.3萬 USD | 1684.3萬 USD |
| 銷售、一般及管理費用 | 1.03億 USD | 1.47億 USD | 1.2億 USD | 9756.3萬 USD | 9756.3萬 USD |
| 營業費用 | 1.2億 USD | 2.14億 USD | 1.36億 USD | 1.14億 USD | 1.14億 USD |
| 利息支出 | 236.1萬 USD | 550.3萬 USD | 614.2萬 USD | 468.9萬 USD | 468.9萬 USD |
| 折舊和攤銷 | 2771.2萬 USD | 3075.7萬 USD | 2748.7萬 USD | 2276.5萬 USD | 2024.7萬 USD |
| 營業利益 | −3680.6萬 USD | −1.15億 USD | −3190.4萬 USD | −1782.9萬 USD | −1782.9萬 USD |
| 淨利 | 7830.1萬 USD | −9958.7萬 USD | −3733.3萬 USD | −2.76億 USD | −2.76億 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$19.21
上漲空間 14.07%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2438.19萬0.00%2.3兆 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM2242.09萬0.03%787.4億 USD0.19%US$277.9-0.37%
Vanguard Extended Market ETFVXF936.08萬0.01%954億 USD0.05%US$233.52-0.63%
Dimensional - US Small Cap ETFDFAS531.95萬0.02%338.69億 USD0.31%US$78.17-0.23%
Schwab U.S. Small-Cap ETFSCHA469.27萬0.02%218.24億 USD0.03%US$32.66-0.40%
Vanguard Russell 2000 ETFVTWO455.27萬0.02%180億 USD0.06%US$112.27-0.35%
Dimensional - US Core Equity 2 ETFDFAC433.75萬0.00%885.96億 USD0.21%US$45.31-0.04%
U.S. Micro Cap Portfolio ETFDFMC272.91萬0.04%75.58億 USD0.43%US$57.70-0.20%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
Schwab U.S. Small-Cap ETFSCHA
Vanguard Russell 2000 ETFVTWO
Dimensional - US Core Equity 2 ETFDFAC
U.S. Micro Cap Portfolio ETFDFMCAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。